Endovascular repair combined with in situ fenestration for new‐onset or residual arch dissection in patients underwent aortic replacement
Journal of Medical Imaging and Radiation Oncology · 2024
DOI: 10.1111/1754-9485.13572 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Imaging and Radiation Oncology, 2024. Verfasst von Zhexin Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Aortic Aneurysm, Thoracic, Blood Vessel Prosthesis Implantation, Endovascular Procedures, Aortic Dissection. Die Arbeit nennt 16 Literaturangaben. Gefördert von: Clinical Research Plan of SHDC, Songjiang District Committee of Science and Technology.
Abstract (Originalsprache)
Introduction
Ascending aorta or hemi‐arch replacement is a frequently used treatment for patients with acute type A thoracic aortic dissection, particularly those who are elderly or have multiple comorbidities. However, in cases where there are secondary entry tears in the aortic arch or descending aorta, this procedure may not fully resolve the issue. The true lumen may remain compressed due to perfusion of the false lumen and usually require reoperation.
Methods
Between January 2019 and July 2022, 18 patients underwent endovascular total aortic arch repair and fenestration technique without requiring median re‐sternotomy. Aortic stent grafts were implanted via the femoral approach, utilizing prosthetic vessels as an appropriate proximal landing zone for aortic stent graft deployment. Based on the debranching conditions of the arch in previous surgery, single, double or triple in situ fenestrations (ISFs) were performed, respectively.
Results
All 18 cases were technically successful, with a median follow‐up period of 20 months (range: 18–31 months). All patients had a favourable postoperative course, with no deaths within 30 days or during their hospital stay. There were no instances of disabling stroke, paraplegia, endo‐leak, stent graft migration or stent graft‐induced new entry. In addition, all patients exhibited complete thrombosis of the false lumen at the level of the aortic arch.
Conclusion
Our preliminary experience suggests that endovascular total arch repair combined with ISF technique is a viable, effective and safe option for treatment. Our mid‐term results have been promising, but we acknowledge the need for further evaluation to assess long‐term outcomes and durability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
- Department of Nursing, Shanghai East Hospital, Tong Ji University, School of Medicine, Shanghai, China.
- Department of Emergency and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Förderung
- Clinical Research Plan of SHDC
- Songjiang District Committee of Science and Technology
Zitieren
APA
Lu, Z., Huang, J., Fan, Y., Gu, H., Zhu, X., Yu, M., & Ye, Y. (2024). Endovascular repair combined with in situ fenestration for new‐onset or residual arch dissection in patients underwent aortic replacement. Journal of Medical Imaging and Radiation Oncology. https://doi.org/10.1111/1754-9485.13572
Vancouver
Lu Z, Huang J, Fan Y, Gu H, Zhu X, Yu M, et al. Endovascular repair combined with in situ fenestration for new‐onset or residual arch dissection in patients underwent aortic replacement. Journal of Medical Imaging and Radiation Oncology. 2024. doi:10.1111/1754-9485.13572
BibTeX
@article{Lu2024,
author = {Lu, Zhexin and Huang, Jin and Fan, Yongliang and Gu, Hongbing and Zhu, Xian and Yu, Min and Ye, Yizhou},
title = {Endovascular repair combined with in situ fenestration for new‐onset or residual arch dissection in patients underwent aortic replacement},
journal = {Journal of Medical Imaging and Radiation Oncology},
year = {2024},
doi = {10.1111/1754-9485.13572}
}
EUVIMED